Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Young men with male pattern baldness lose hair density over time without treatment.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Androgens may block hair growth signals, targeting this could treat hair loss.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.